Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Pediatr Surg ; 46(3): 489-95, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21376198

RESUMEN

BACKGROUND: Necrotizing enterocolitis (NEC) is a devastating intestinal disease of premature infants. Although ω-3 fatty acids are known to have antiinflammatory effects, their effect against NEC remains unclear. METHODS: Mother rats fed a soybean-based, docosahexaenoic acid (DHA)- or eicosapentaenoic acid (EPA)-enriched diet from days 7 to 20 of gestation were examined. On day 20, the rat pups were delivered by abdominal incision, their intestines were removed, and messenger RNA was extracted. A rat NEC model was used to confirm the effects of ω-3 fatty acids on the inflamed intestine (n = 20-28). The expression of inflammatory molecules was analyzed by real-time polymerase chain reaction (n = 11-14). RESULTS: The concentrations of DHA and EPA in the intestine were significantly increased in the DHA and EPA groups (P < .01). The expression of the antiinflammatory prostaglandin E2 receptor EP3 was increased in the DHA (P < .05) and EPA groups (P < .01). In the NEC model, the reduced incidence of colitis was confirmed in the DHA and EPA groups. The expression of peroxisome proliferator-activated receptor γ was increased (P < .05), and the inhibitor of nuclear factor-κB α/ß decreased in both the DHA (P < .01) and EPA groups (P < .05). CONCLUSION: Our findings indicate that ω-3 fatty acids are beneficial for protecting the premature intestine from inflammation by regulating eicosanoid- and nuclear factor-κB-related metabolite expression.


Asunto(s)
Antiinflamatorios/uso terapéutico , Grasas Insaturadas en la Dieta/uso terapéutico , Ácidos Docosahexaenoicos/uso terapéutico , Ácido Eicosapentaenoico/uso terapéutico , Enterocolitis Necrotizante/prevención & control , Animales , Animales Recién Nacidos , Antiinflamatorios/administración & dosificación , Antiinflamatorios/farmacología , Grasas Insaturadas en la Dieta/administración & dosificación , Modelos Animales de Enfermedad , Ácidos Docosahexaenoicos/administración & dosificación , Ácidos Docosahexaenoicos/farmacología , Evaluación Preclínica de Medicamentos , Ácido Eicosapentaenoico/administración & dosificación , Ácido Eicosapentaenoico/farmacología , Enterocolitis Necrotizante/inducido químicamente , Ácidos Grasos/análisis , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Íleon/química , Íleon/efectos de los fármacos , Íleon/embriología , Alimentos Infantiles/toxicidad , Mucosa Intestinal/efectos de los fármacos , Intercambio Materno-Fetal , Modelos Animales , FN-kappa B/efectos de los fármacos , PPAR gamma/biosíntesis , PPAR gamma/genética , Embarazo , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Subtipo EP3 de Receptores de Prostaglandina E/biosíntesis , Subtipo EP3 de Receptores de Prostaglandina E/genética , Aceite de Soja , Organismos Libres de Patógenos Específicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA